Narido Richard Clavano 4
4 · Lucira Health, Inc. · Filed Dec 6, 2022
Insider Transaction Report
Form 4
Narido Richard Clavano
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1]2022-12-01$0.36/sh−1,583$570→ 107,293 total
Footnotes (1)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 30, 2021 for 69,975 shares.
Signature
/s/ Richard Narido|2022-12-06